MYBBP1A and cancer: Originally, MYBBP1A was reported as mapping to 17p13.3, where the loss of heterozygosity is observed with high frequency (50%–80%) in different types of cancer, including sporadic breast and ovarian cancer, medulloblastomas, astrocytomas, osteosarcomas, leukemias, bladder cancer and lung cancer [58].